Dr Philip Taylor
Prosiectau fel Prif Ymchwiliwr
- A combination of in silico and in vitro studies to understand the regulation of microglia by the novel Alzheimer’s disease risk gene ATP8B4 (01.10.2023 - 30.09.2026)
- A framework for the use human iPSC-derived microglial cultures in translational platforms (01.10.2021 - 30.03.2025)
- Collective role of myeloid lectins in host-defence and immunity (01.11.2011 - 30.09.2012)
- Control of homeostasis and anti-microbial immunity by the macrophage metabolome (05.05.2015 - 31.05.2019)
- Defining the role of peritoneal dendritic cells in tissue specific immunity and the clinical application of peritoneal dialysis (01.08.2013 - 31.07.2016)
Prosiectau fel Cyd-Ymchwiliwr
- In vitro and in vivo evaluation of the anti-inflammatory efficacy of Toll-like receptor 2-derived peptides (01.04.2009 - 31.03.2012)
- Regulation of myeloid cells in innate immune inflammation (01.11.2006 - 31.01.2008)
- The Moondance Dementia Research Laboratory (01.09.2023 - 31.08.2028)
- UK DRI IPSC platform to model Alzheimer's disease risk (IPMAR) (08.01.2021 - 31.10.2023)